Tamoxifen related side effects and their impact on breast cancer incidence: A retrospective analysis of the randomised IBIS-I trial

BACKGROUND: Studies in the adjuvant setting have shown that endocrine therapy related side effects predict breast cancer recurrence risk. Here, we assess the relationship between early reported side effects and incidence of breast cancer in women randomised to tamoxifen for cancer prevention in the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hale, Michael J., Howell, Anthony, Dowsett, Mitch, Cuzick, Jack, Sestak, Ivana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649356/
https://www.ncbi.nlm.nih.gov/pubmed/33160147
http://dx.doi.org/10.1016/j.breast.2020.10.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649356/
https://www.ncbi.nlm.nih.gov/pubmed/33160147
http://dx.doi.org/10.1016/j.breast.2020.10.015

Ejemplares similares